Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targets and Antibody Formats for Immunotherapy of Neuroblastoma
Jeong A Park, Nai‐Kong V. Cheung
Journal of Clinical Oncology (2020) Vol. 38, Iss. 16, pp. 1836-1848
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Molecular targeting therapies for neuroblastoma: Progress and challenges
Atif Zafar, Wei Wang, Gang Liu, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 2, pp. 961-1021
Open Access | Times Cited: 260
Advancing therapy for neuroblastoma
Bo Qiu, Katherine K. Matthay
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 8, pp. 515-533
Closed Access | Times Cited: 222
The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology
Judith Wienke, Miranda P. Dierselhuis, Godelieve A.M. Tytgat, et al.
European Journal of Cancer (2020) Vol. 144, pp. 123-150
Open Access | Times Cited: 148
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
Qing Wu, Wei Qian, Xiaoli Sun, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 135
Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives
Nora Berois, Álvaro Pittini, Eduardo Osinaga
Cancers (2022) Vol. 14, Iss. 3, pp. 645-645
Open Access | Times Cited: 77
Immunotherapy of Neuroblastoma: Facts and Hopes
John Anderson, Robbie G. Majzner, Paul M. Sondel
Clinical Cancer Research (2022) Vol. 28, Iss. 15, pp. 3196-3206
Open Access | Times Cited: 71
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
Roel Polak, Elisa Zhang, Calvin J. Kuo
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 523-539
Closed Access | Times Cited: 48
Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities
Nanhao Yin, Xintong Li, Xuanwei Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
PD-1/PD-L1 in Cancer: Pathophysiological, Diagnostic and Therapeutic Aspects
Enrico Munari, Francesca Romana Mariotti, Linda Quatrini, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5123-5123
Open Access | Times Cited: 87
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies
Kristina Lundberg, Diana Treis, John Inge Johnsen
Current Oncology Reports (2022) Vol. 24, Iss. 8, pp. 1053-1062
Open Access | Times Cited: 52
Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma
Gcf Chan, Carol Matias Chan
Biomolecules (2022) Vol. 12, Iss. 3, pp. 358-358
Open Access | Times Cited: 40
Targeting macrophages in cancer immunotherapy: Frontiers and challenges
Yue Liu, Huabing Tan, Jingyuan Dai, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Adults and Adolescents With Neuroblastoma: An Analysis of the National Cancer Database
Charbel Chidiac, Katherine M. McDermott, Caitlyn Ramdat, et al.
Journal of Surgical Oncology (2025)
Closed Access | Times Cited: 1
Differentiating Neuroblastoma: A Systematic Review of the Retinoic Acid, Its Derivatives, and Synergistic Interactions
Nadiya Bayeva, Erin Coll, Olga Piskareva
Journal of Personalized Medicine (2021) Vol. 11, Iss. 3, pp. 211-211
Open Access | Times Cited: 52
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Yifan Xie, Feng Xie, Lei Zhang, et al.
Advanced Science (2021) Vol. 8, Iss. 22
Open Access | Times Cited: 52
Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies
Chiara Vitale, Monica Marzagalli, Silvia Scaglione, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1013-1013
Open Access | Times Cited: 30
B7-H3 in Brain Malignancies: Immunology and Immunotherapy
Xiaopeng Guo, Mengqi Chang, Yu Wang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 12, pp. 3762-3780
Open Access | Times Cited: 20
Immunotherapeutic Strategies for Neuroblastoma: Present, Past and Future
Fabio Morandi, Federica Sabatini, Marina Podestà, et al.
Vaccines (2021) Vol. 9, Iss. 1, pp. 43-43
Open Access | Times Cited: 33
Engineering magnetic nano-manipulators for boosting cancer immunotherapy
Bin Yan, Siyao Wang, Chen Liu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 25
LncRNAs and CircRNAs in cancer
Xin Yin, Huiran Lin, Lei Lin, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 24
Single-cell landscape analysis reveals distinct regression trajectories and novel prognostic biomarkers in primary neuroblastoma
Qingqing Liu, Zhenni Wang, Yan Jiang, et al.
Genes & Diseases (2022) Vol. 9, Iss. 6, pp. 1624-1638
Open Access | Times Cited: 23
Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma
Jasmine Y. Lee, Hunter C. Jonus, Arhanti Sadanand, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 6, pp. 101091-101091
Open Access | Times Cited: 13
Carbon nanodots constructed by ginsenosides and their high inhibitory effect on neuroblastoma
Yingnan Jiang, Lizhi Xiao, Jifeng Wang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Engaging plasticity: Differentiation therapy in solid tumors
Neta Bar-Hai, Dana Ishay-Ronen
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors
Daniel Kalinovsky, А. В. Кибардин, И. В. Холоденко, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004646-e004646
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top